Advertisement
Screener

Vivos Therapeutics, Inc. (VVOS) Income (Loss) from Continuing Operations before Income Taxes, Domestic

1.4 / 5 stars · 15/52 Roast Me

Vivos Therapeutics, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic

Vivos Therapeutics, Inc. (VVOS) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$21.23 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.

Financial Statements › Income Statement › Pre-tax Income

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-04-15

  • Vivos Therapeutics, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$21.23M.
  • Vivos Therapeutics, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$11.19M.
  • Vivos Therapeutics, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$13.63M.
  • Vivos Therapeutics, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$23.95M.
Period endIncome (Loss) from Continuing Operations before Income Taxes, Domestic 12 month
2025-12-31-$21.23M
10-K · filed 2026-04-15
2024-12-31-$11.19M
10-K · filed 2026-04-15
2023-12-31-$13.63M
10-K · filed 2025-03-31
2022-12-31-$23.95M
10-K/A · filed 2024-07-30
2021-12-31-$20.31M
10-K · filed 2023-03-30
2020-12-31-$12.07M
10-K · filed 2022-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
NEXGEL, INC. (NXGL)United States$0.002B
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
Tenon Medical, Inc. (TNON)United States$0.002B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Profusa, Inc. (PFSA)United States$0.002B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B